vs

Side-by-side financial comparison of LIVEPERSON INC (LPSN) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

LIVEPERSON INC is the larger business by last-quarter revenue ($59.3M vs $44.6M, roughly 1.3× PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). LIVEPERSON INC runs the higher net margin — -77.8% vs -90.4%, a 12.7% gap on every dollar of revenue. On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs -19.0%). LIVEPERSON INC produced more free cash flow last quarter ($-12.0M vs $-19.9M). Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs -16.6%).

LivePerson is a global technology company that develops conversational commerce and AI software.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

LPSN vs PACB — Head-to-Head

Bigger by revenue
LPSN
LPSN
1.3× larger
LPSN
$59.3M
$44.6M
PACB
Growing faster (revenue YoY)
PACB
PACB
+32.8% gap
PACB
13.8%
-19.0%
LPSN
Higher net margin
LPSN
LPSN
12.7% more per $
LPSN
-77.8%
-90.4%
PACB
More free cash flow
LPSN
LPSN
$8.0M more FCF
LPSN
$-12.0M
$-19.9M
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
-16.6%
LPSN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LPSN
LPSN
PACB
PACB
Revenue
$59.3M
$44.6M
Net Profit
$-46.1M
$-40.4M
Gross Margin
73.2%
37.1%
Operating Margin
-68.7%
-92.3%
Net Margin
-77.8%
-90.4%
Revenue YoY
-19.0%
13.8%
Net Profit YoY
58.9%
-1802.7%
EPS (diluted)
$-9.22
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LPSN
LPSN
PACB
PACB
Q4 25
$59.3M
$44.6M
Q3 25
$60.2M
$38.4M
Q2 25
$59.6M
$39.8M
Q1 25
$64.7M
$37.2M
Q4 24
$73.2M
$39.2M
Q3 24
$74.2M
$40.0M
Q2 24
$79.9M
$36.0M
Q1 24
$85.1M
$38.8M
Net Profit
LPSN
LPSN
PACB
PACB
Q4 25
$-46.1M
$-40.4M
Q3 25
$8.7M
$-38.0M
Q2 25
$-15.7M
$-41.9M
Q1 25
$-14.1M
$-426.1M
Q4 24
$-112.1M
$2.4M
Q3 24
$-28.3M
$-60.7M
Q2 24
$41.8M
$-173.3M
Q1 24
$-35.6M
$-78.2M
Gross Margin
LPSN
LPSN
PACB
PACB
Q4 25
73.2%
37.1%
Q3 25
71.4%
41.4%
Q2 25
69.7%
36.9%
Q1 25
71.8%
-3.7%
Q4 24
77.4%
25.6%
Q3 24
73.1%
25.0%
Q2 24
79.4%
16.5%
Q1 24
71.3%
29.1%
Operating Margin
LPSN
LPSN
PACB
PACB
Q4 25
-68.7%
-92.3%
Q3 25
-24.2%
-101.1%
Q2 25
-10.8%
-112.8%
Q1 25
-26.2%
-1154.5%
Q4 24
-138.0%
-390.1%
Q3 24
-21.6%
-160.3%
Q2 24
-37.3%
-488.3%
Q1 24
-42.7%
-209.6%
Net Margin
LPSN
LPSN
PACB
PACB
Q4 25
-77.8%
-90.4%
Q3 25
14.5%
-98.9%
Q2 25
-26.4%
-105.4%
Q1 25
-21.8%
-1146.8%
Q4 24
-153.2%
6.0%
Q3 24
-38.1%
-151.9%
Q2 24
52.3%
-481.3%
Q1 24
-41.8%
-201.4%
EPS (diluted)
LPSN
LPSN
PACB
PACB
Q4 25
$-9.22
$-0.11
Q3 25
$-2.76
$-0.13
Q2 25
$-0.17
$-0.14
Q1 25
$-0.24
$-1.44
Q4 24
$-17.23
$-0.44
Q3 24
$-4.74
$-0.22
Q2 24
$-0.33
$-0.64
Q1 24
$-0.40
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LPSN
LPSN
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$95.0M
$279.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$-44.5M
$5.3M
Total Assets
$454.7M
$784.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LPSN
LPSN
PACB
PACB
Q4 25
$95.0M
$279.5M
Q3 25
$106.7M
$298.7M
Q2 25
$162.0M
$314.7M
Q1 25
$176.3M
$343.1M
Q4 24
$183.2M
$389.9M
Q3 24
$142.1M
$471.1M
Q2 24
$146.0M
$509.8M
Q1 24
$127.1M
$561.9M
Total Debt
LPSN
LPSN
PACB
PACB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
$512.1M
Stockholders' Equity
LPSN
LPSN
PACB
PACB
Q4 25
$-44.5M
$5.3M
Q3 25
$-22.1M
$36.1M
Q2 25
$-82.4M
$61.5M
Q1 25
$-74.9M
$91.6M
Q4 24
$-67.3M
$506.6M
Q3 24
$45.9M
$453.1M
Q2 24
$66.6M
$492.7M
Q1 24
$19.2M
$649.0M
Total Assets
LPSN
LPSN
PACB
PACB
Q4 25
$454.7M
$784.1M
Q3 25
$511.4M
$803.2M
Q2 25
$604.2M
$825.5M
Q1 25
$596.2M
$860.8M
Q4 24
$607.8M
$1.3B
Q3 24
$692.0M
$1.5B
Q2 24
$703.8M
$1.5B
Q1 24
$724.7M
$1.7B
Debt / Equity
LPSN
LPSN
PACB
PACB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
26.69×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LPSN
LPSN
PACB
PACB
Operating Cash FlowLast quarter
$-9.7M
$-19.1M
Free Cash FlowOCF − Capex
$-12.0M
$-19.9M
FCF MarginFCF / Revenue
-20.2%
-44.6%
Capex IntensityCapex / Revenue
3.9%
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-42.5M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LPSN
LPSN
PACB
PACB
Q4 25
$-9.7M
$-19.1M
Q3 25
$-6.0M
$-18.7M
Q2 25
$-11.7M
$-29.4M
Q1 25
$-3.1M
$-44.1M
Q4 24
$-3.1M
$-30.6M
Q3 24
$4.8M
$-45.5M
Q2 24
$-17.9M
$-54.3M
Q1 24
$1.1M
$-75.7M
Free Cash Flow
LPSN
LPSN
PACB
PACB
Q4 25
$-12.0M
$-19.9M
Q3 25
$-8.9M
$-18.8M
Q2 25
$-14.8M
$-29.9M
Q1 25
$-6.9M
$-45.4M
Q4 24
$-6.8M
$-32.3M
Q3 24
$-230.0K
$-46.3M
Q2 24
$-22.9M
$-55.7M
Q1 24
$-10.4M
$-79.6M
FCF Margin
LPSN
LPSN
PACB
PACB
Q4 25
-20.2%
-44.6%
Q3 25
-14.8%
-48.9%
Q2 25
-24.9%
-75.3%
Q1 25
-10.6%
-122.3%
Q4 24
-9.2%
-82.3%
Q3 24
-0.3%
-115.7%
Q2 24
-28.7%
-154.8%
Q1 24
-12.2%
-205.0%
Capex Intensity
LPSN
LPSN
PACB
PACB
Q4 25
3.9%
1.9%
Q3 25
4.8%
0.2%
Q2 25
5.3%
1.4%
Q1 25
5.8%
3.7%
Q4 24
5.0%
4.1%
Q3 24
6.8%
2.0%
Q2 24
6.2%
4.1%
Q1 24
13.5%
10.0%
Cash Conversion
LPSN
LPSN
PACB
PACB
Q4 25
Q3 25
-0.69×
Q2 25
Q1 25
Q4 24
-12.93×
Q3 24
Q2 24
-0.43×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LPSN
LPSN

Hosted Services Business$51.0M86%
Professional Services$8.3M14%

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons